Upset over the Devyani Khobragade episode, India on Wednesday raised with the United States its concerns over "trafficking" visas issued to family members of Sangita Richard, the absconding maid of......
Altaf Ahmed Lal, country head of the US Food and Drug Administration (US FDA) in India, has quit and so have a few other key officials at the American drug regulator's India office. These......
Indian drug makers, slammed for months in the US over issues related to quality and intellectual property rights, might soon get to breathe easy. The US regulator is set to expedite from October......
In this final part of the three-part series on America's war on substandard Indian generic drugs, Aziz Haniffa speaks about US doctors' contempt for drugs exported from India and the ineptitude of......
In the second of a three-part series, Ranbaxy whistleblower Dinesh Thakur tells Aziz Haniffa that a formal Congress hearing on spurious drugs from India is being sought. Part I: War on......
The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain. Ranbaxy whistle-blower Dinesh Thakur,......